Clinical Trial Update: A Study of Replagal in Children and Adults With Fabry Disease in India [Phase 4]

View source ↗

Summary

This entry reports a Phase 4 clinical trial evaluating Replagal (agalsidase alfa) in children and adults with Fabry disease in India, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Drugs mentioned

• Replagal (agalsidase alfa)

Snippet

Sponsor: Shire | Conditions: Fabry Disease | Phase 4 | Status: RECRUITING